英文名稱 |
中文名稱 |
CAS號(hào) |
操作 |
Telotristat Etiprate |
4-[2-氨基-6-[(1R)-1-[4-氯-2-(3-甲基-1H-吡唑-1-基)苯基]-2,2,2-三氟乙氧基]-4-嘧啶基]-L-苯丙氨酸乙酯 N-苯甲酰甘氨酸鹽 |
1137608-69-5 |
詳細(xì)
|
Regorafenib |
瑞格非尼 |
755037-03-7 |
詳細(xì)
|
Ciprofloxacin Impurity E |
環(huán)丙沙星雜質(zhì)E |
105394-83-0 |
詳細(xì)
|
Rifabutin |
利福布汀 |
72559-06-9 |
詳細(xì)
|
Rifabutin EP Impurity D |
3-氨基-4-亞氨基-利福霉素 S |
62041-01-4 |
詳細(xì)
|
Oxyresveratrol 2-O-β-D-glucopyranoside |
氧化白藜蘆醇-2-O-Β-D-吡喃葡萄糖苷 |
392274-22-5 |
詳細(xì)
|
Ofloxacin EP Impurity D |
氧氟沙星EP雜質(zhì)D |
197291-75-1 |
詳細(xì)
|
Tirapazamine |
替拉扎明 |
27314-97-2 |
詳細(xì)
|
Mitoxantrone |
米托蒽醌 |
65271-80-9 |
詳細(xì)
|
Ametantrone |
阿美蒽醌 |
64862-96-0 |
詳細(xì)
|
Oxyresveratrol 3'-O-β-D-glucopyranoside |
氧化白藜蘆醇-3'-O-Β-D-吡喃葡萄糖苷 |
144525-40-6 |
詳細(xì)
|
Methyl 13-cis-4-Oxoretinoate |
4-KETO 13-CIS-RETINOIC ACID |
71748-57-7 |
詳細(xì)
|
Riboflavin, 2',3',4',5'-tetraacetate |
核黃素四乙酸酯 |
752-13-6 |
詳細(xì)
|
Amonafide |
氨萘非特 |
69408-81-7 |
詳細(xì)
|
Pirarubicin |
吡柔比星 |
72496-41-4 |
詳細(xì)
|
N-methyl-N-(4-nitrophenyl)-2-(piperazin-1-yl)acetamide |
尼達(dá)尼布雜質(zhì) |
1038972-16-5 |
詳細(xì)
|
(R)-Omeprazole Sodium Salt |
5-甲氧基-2-[(4-甲氧基-3,5-二甲基-2-吡啶基)-甲基]-3H-苯并咪唑鈉鹽 |
161796-77-6 |
詳細(xì)
|
N-methyl-N-(4-nitrophenyl)-2-(piperazin-1-yl)acetamide hydrochloride |
尼達(dá)尼布雜質(zhì) |
2037385-84-3 |
詳細(xì)
|
N-Methyl-2-(4-methyl-1-piperazinyl)-N-(4-nitrophenyl)acetamide |
N,4-二甲基-N-(4-硝基苯基)-1-哌嗪乙酰胺 |
1139453-98-7 |
詳細(xì)
|
SHP099 HCl |
SHP-099鹽酸鹽 |
1801747-11-4 |
詳細(xì)
|
Rivaroxaban Amine Impurity |
利伐沙班雜質(zhì)J |
1151893-81-0 |
詳細(xì)
|
Omeprazole Related Compound 10 |
奧美拉唑雜質(zhì) |
142885-92-5 |
詳細(xì)
|
Anatabine |
新煙草堿(去氫新煙堿) |
2743-90-0 |
詳細(xì)
|
RGW 611 |
4-(2-(4-NITRO-1H-IMIDAZOL-1-YL)ETHYL)MORPHOLINE |
6497-78-5 |
詳細(xì)
|
4-Hydroxy Omeprazole Sodium Salt |
2-(((3,5-二甲基-4-氧化吡啶-2-基)甲基)亞磺?;?-5-甲氧基苯并[d]咪唑-1-鈉 |
1803449-15-1 |
詳細(xì)
|
Rivaroxaban Impurity A hydrochloride |
利伐沙班雜質(zhì)25 |
931117-61-2 |
詳細(xì)
|
6-Bromo-8-cyclopentyl-2-[[5-(4-Boc-1-piperazinyl)-2-pyridyl]amino]-5-methylpyrido[2,3-d]pyrimidin-7(8H)-one |
帕布昔利布雜質(zhì)23 |
571188-82-4 |
詳細(xì)
|
3-(5-Methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)benzenamine |
尼洛替尼雜質(zhì) |
641571-16-6 |
詳細(xì)
|
4-(2,4-Diaminophenyl)morpholin-3-one |
利伐沙班雜質(zhì)21 |
482308-13-4 |
詳細(xì)
|
Methyl 1-Acetyl-2-oxoindoline-6-carboxylate |
1-乙酰基-2,3-二氫-2-氧代-1H-吲哚-6-羧酸甲酯 |
676326-36-6 |
詳細(xì)
|
Olaparib |
奧拉帕尼 |
763113-22-0 |
詳細(xì)
|
7-Troc-paclitaxel |
7-(2,2,2-三氯乙基氧基羰基)紫杉醇 |
114915-17-2 |
詳細(xì)
|
7-Epi-10-deacetyltaxol |
7-表-10-去乙?;颇献仙紝嶢 |
78454-17-8 |
詳細(xì)
|
Rivaroxaban Pseudodimer |
利伐沙班開環(huán)二聚體 |
1632463-24-1 |
詳細(xì)
|
5-bromo-4-chloro-N-cyclopentylpyrimidin-2-amine |
帕布昔利布雜質(zhì) |
1823404-28-9 |
詳細(xì)
|
1,4-Bis(4-nitrophenyl)piperazine |
1,4-雙(4-硝基苯基)哌嗪 |
16264-05-4 |
詳細(xì)
|
6-Desacetyl-6-Bromo Palbociclib |
PALBOCICLIB雜質(zhì)A |
851067-56-6 |
詳細(xì)
|
Tert-butyl 4-(6-((6-(1-butoxyvinyl)-8-cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl)amino)pyridin-3-yl)piperazine-1-carboxylate |
2-甲基-2-丙基-4-(6 - {[8-環(huán)戊基-5-甲基-7-氧代-6-(1-丁氧乙烯基)-7,8-二氫吡啶并[2,3-D]嘧啶-2-基]氨基} -3-吡啶基)-1-哌嗪甲酸 |
866084-31-3 |
詳細(xì)
|
Pabociclib Impurity B Hydrochloride |
帕布昔利布雜質(zhì) |
1883672-48-7 |
詳細(xì)
|
tert-butyl 4-(6-((8-cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl)amino)pyridin-3-yl)piperazine-1-carboxylate |
帕布昔利布雜質(zhì)X |
571189-65-6 |
詳細(xì)
|
Bisoprolol EP Impurity L |
鹽酸美托洛爾雜質(zhì)3 |
1956321-87-1 |
詳細(xì)
|
Pemetrexed Impurity E Disodium Salt |
培美曲塞雜質(zhì)E |
937370-10-0 |
詳細(xì)
|
SPHINX31 |
CS-2837 |
1818389-84-2 |
詳細(xì)
|
GSK-2018682 |
CPD1224 |
1034688-30-6 |
詳細(xì)
|
WEHI-345 |
N-[2-[4-氨基-3-(4-甲基苯基)-1H-吡唑并[3,4-D]嘧啶-1-基]-2-甲基丙基]-4-吡啶甲酰胺 |
1354825-58-3 |
詳細(xì)
|
GSK2982772 |
GSK2982772 |
1622848-92-3 |
詳細(xì)
|
RBC8 |
RBC8 |
361185-42-4 |
詳細(xì)
|
Tenapanor |
CS-2459 |
1234423-95-0 |
詳細(xì)
|
1-Methylpyridin-1-ium-2-carboxamide |
氯解磷定 |
45750-74-1 |
詳細(xì)
|
Dicresulene |
地瑞舒林 |
78480-14-5 |
詳細(xì)
|
BAR-501 |
CPDD0945 |
1632118-69-4 |
詳細(xì)
|
MTIC |
3-甲基(三氮雜烯基)咪唑-4 甲酰胺 |
3413-72-7 |
詳細(xì)
|
Paliperidone Palmitate |
棕櫚酸帕利哌酮 |
199739-10-1 |
詳細(xì)
|
2,5-Dioxopyrrolidine Sacubitril |
原研550-06 |
1038924-97-8 |
詳細(xì)
|
N-[[[(1R)-2-(6-Amino-9H-purin-9-yl)-1-methylethoxy]methyl]hydroxyphosphinyl]-D-alanine |
替諾福韋雜質(zhì)134 |
376633-24-8 |
詳細(xì)
|
Safinamide Impurity 8 |
沙芬酰胺雜質(zhì)8 |
690969-16-5 |
詳細(xì)
|
Rivastigmine USP Related Compound F |
N-乙基-N-甲基-3-乙烯苯基氨基甲酸酯 |
1346602-84-3 |
詳細(xì)
|
Pidotimod Impurity Y |
匹多莫德雜質(zhì)Y |
161771-76-2 |
詳細(xì)
|
N-2-[2-(2,2,2-Trifluoroethoxy)phenoxy]ethylsilodosin |
西洛多辛雜質(zhì)19 |
1453221-45-8 |
詳細(xì)
|
Nimesulide Impurity F |
N-(甲基磺?;?-4'-硝基-2'-苯氧基甲烷磺酰苯胺 |
51765-72-1 |
詳細(xì)
|
Tenofovir Disoproxil Isopropoxycarbonyl |
替諾福韋氨基甲酸酯 |
1244022-54-5 |
詳細(xì)
|
((R)-2-Biphenyl-4-yl-1-formylethyl)carbamic Acid t-Butyl Ester |
AHU-377中間體2 |
149709-58-0 |
詳細(xì)
|
Sitagliptin FP Impurity C |
西格列汀雜質(zhì) |
1803026-58-5 |
詳細(xì)
|
Sitagliptin FP Impurity D |
西格列汀雜質(zhì)05 |
1253056-18-6 |
詳細(xì)
|
(3R,5S)-5-Biphenyl-4-ylmethyl-3-methylpyrrolidin-2-one |
LCZ696中間體1 |
1038924-70-7 |
詳細(xì)
|
(2R)-2-[[4-[(3-fluorophenyl)methoxy]phenyl]methylamino]propanamide |
沙芬酰胺對(duì)映異構(gòu)體 |
174756-44-6 |
詳細(xì)
|
Sparsentan (RE-021) |
4'-[(2-丁基-4-氧代-1,3-二氮雜螺[4.4]壬-1-烯-3-基)甲基]-N-(4,5-二甲基-3-異惡唑基)-2'-(乙氧基甲基)-[1,1'-聯(lián)苯]-2-磺酰胺 |
254740-64-2 |
詳細(xì)
|
Enalapril EP Impurity D |
依那普利二酮哌嗪 |
115729-52-7 |
詳細(xì)
|
Nimesulide Impurity E |
N-(甲基磺?;?-N-(2-苯氧基苯基)甲烷磺酰胺 |
905858-63-1 |
詳細(xì)
|
Sitagliptin impurity D |
N-乙?;魉型?/td>
| 1379666-94-0 |
詳細(xì)
|
Safinamide Impurity 5 |
沙芬酰胺雜質(zhì)5 |
1160513-60-9 |
詳細(xì)
|
Sofosbuvir Impurity (GS-566500) |
N-[(2'R)-2'-脫氧-2'-氟-2'-甲基-5'-尿苷?;鵠-L-丙氨酸 |
1233335-78-8 |
詳細(xì)
|
(3alpha,5beta,6beta,7alpha)-6-Ethylcholane-3,7,24-triol |
BAR 501 IMPURITY |
1632118-70-7 |
詳細(xì)
|
Sitagliptin Fumarate Adduct (Mixture of Diastereomers) |
西他列汀雜質(zhì)21 |
2088771-60-0 |
詳細(xì)
|
Clopidogrel Related Compound B |
氯吡咯雷雜質(zhì)B |
144750-52-7 |
詳細(xì)
|
Humulone |
律草酮 |
26472-41-3 |
詳細(xì)
|
Pidotimod Impurity X |
匹多莫德雜質(zhì)X |
161771-75-1 |
詳細(xì)
|
Clopidogrel Related Compound A |
氯吡格雷酸 |
144457-28-3 |
詳細(xì)
|
2,2'-(2-propyl-1-((2'-(1-trityl-1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-1H-imidazole-4,5-diyl)bis(propan-2-ol) |
奧美沙坦酯雜質(zhì) |
1418133-29-5 |
詳細(xì)
|
Lepirudin |
來匹盧定 |
138068-37-8 |
詳細(xì)
|
Ethyl 3,5-bis(benzyloxy)benzoate |
特布他林雜質(zhì) |
50841-46-8 |
詳細(xì)
|
2-Bromo-3',5'-dibenzyloxyacetphenone |
2-溴-3'.5'-二芐氧基苯乙酮 |
28924-18-7 |
詳細(xì)
|
1-(3,5-bis(benzyloxy)phenyl)-2-(tert-butylamino)ethanone |
硫酸特比萘芬雜質(zhì)J |
52144-90-8 |
詳細(xì)
|
Benzyl 3,5-bis(phenylmethoxy)benzoate |
特布他林雜質(zhì) |
50513-72-9 |
詳細(xì)
|
2-(benzyl(tert-butyl)amino)-1-(3,5-bis(benzyloxy)phenyl)ethanone sulfate (2:1) |
特布他林雜質(zhì) |
52144-93-1 |
詳細(xì)
|
2-(benzyl(tert-butyl)amino)-1-(3,5-bis(benzyloxy)phenyl)ethanone |
特布他林雜質(zhì)4 |
52144-92-0 |
詳細(xì)
|
Tenofovir Related Compound 1 |
替諾福韋拉酚氨酯雜質(zhì)04 |
342631-41-8 |
詳細(xì)
|
Tetracaine Impurity C |
4-丁氨基苯甲酸甲酯 |
71839-12-8 |
詳細(xì)
|
Dimethyl 2-propyl-1-((2'-(1-trityl-1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-1H-imidazole-4,5-dicarboxylate |
奧美沙坦酯雜質(zhì)R |
144690-53-9 |
詳細(xì)
|
FMK |
FMK |
821794-92-7 |
詳細(xì)
|
Salirasib |
法尼基硫代水楊酸 |
162520-00-5 |
詳細(xì)
|
6-Desacetyl Palbociclib Hydrochloride |
帕布昔利布雜質(zhì)20 |
571189-66-7 |
詳細(xì)
|
CU-CPT-9b |
CU-CPT-9B, CPD2004 |
2165340-32-7 |
詳細(xì)
|
(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 4-(2-methoxypropan-2-yl)-2-propyl-1-((2'-(1-trityl-1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-1H-imidazole-5-carboxylate |
奧美沙坦酯雜質(zhì) |
1040405-56-8 |
詳細(xì)
|
1-(4-(2-hydroxypropan-2-yl)-2-propyl-1-((2'-(1-trityl-1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-1H-imidazol-5-yl)ethanone |
奧美沙坦雜質(zhì)3 |
1227626-50-7 |
詳細(xì)
|
CPI-1189 |
N-叔丁基-4-乙酰氨基苯甲酰胺 |
183619-38-7 |
詳細(xì)
|
CU-CPT-9a |
CPD1577 |
2162962-69-6 |
詳細(xì)
|
Necrostatin-1 |
NECROSTATIN-1 |
4311-88-0 |
詳細(xì)
|
CU-CPT-8m |
CPD1578 |
125079-83-6 |
詳細(xì)
|
Raxatrigine |
GSK1014802 |
934240-30-9 |
詳細(xì)
|